Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
20.09.2024 / 14:15 CET/CEST
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
1. Details of the person discharging managerial responsibilities / person
closely associated
a) Name
┌───────────────┬────────────────────┐
│ Title: │ │
├───────────────┼────────────────────┤
│ First name: │ Eva │
├───────────────┼────────────────────┤
│ Last name(s): │ Prieschl-Grassauer │
└───────────────┴────────────────────┘
2. Reason for the notification
a) Position / status
┌───────────┬─────────────────────────────┐
│ Position: │ Member of the managing body │
└───────────┴─────────────────────────────┘
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name
┌──────────────────────┐
│ Marinomed Biotech AG │
└──────────────────────┘
b) LEI
┌───────────────────────┐
│ 529900GN3B1EN80XF405 │
└───────────────────────┘
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument,
identification code
┌───────┬──────────────┐
│ Type: │ Share │
├───────┼──────────────┤
│ ISIN: │ ATMARINOMED6 │
└───────┴──────────────┘
b) Nature of the transaction
┌─────────────┐
│ Acquisition │
└─────────────┘
c) Price(s) and volume(s)
┌──────────┬─────────────┐
│ Price(s) │ Volume(s) │
├──────────┼─────────────┤
│ 5 EUR │ 10000 Units │
└──────────┴─────────────┘
d) Aggregated information
┌───────┬───────────────────┐
│ Price │ Aggregated volume │
├───────┼───────────────────┤
│ 5 EUR │ 10000 Units │
└───────┴───────────────────┘
e) Date of the transaction
┌───────────────────┐
│ 18/09/2024; UTC+2 │
└───────────────────┘
f) Place of the transaction
┌─────────────────────────┐
│ Outside a trading venue │
└─────────────────────────┘
══════════════════════════════════════════════════════════════════════════
20.09.2024 CET/CEST
══════════════════════════════════════════════════════════════════════════
Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Internet: www.marinomed.com
End of News EQS News Service
94383 20.09.2024 CET/CEST
